| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Tarr Mark J | President & CEO, Director | 9001 LIBERTY PARKWAY, BIRMINGHAM | /s/ Patrick Darby, attorney-in-fact for Mark J. Tarr | 12 Feb 2026 | 0001304057 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EHC | Encompass Health Common Stock | Sale | $1,751,814 | -16,216 | -3.1% | $108.03 | 510,854 | 11 Feb 2026 | Direct | F1 |
| transaction | EHC | Encompass Health Common Stock | Sale | $1,439,533 | -13,231 | -2.6% | $108.80 | 497,623 | 11 Feb 2026 | Direct | F2 |
| transaction | EHC | Encompass Health Common Stock | Sale | $1,715,331 | -15,584 | -3.1% | $110.07 | 482,039 | 11 Feb 2026 | Direct | F3 |
| transaction | EHC | Encompass Health Common Stock | Sale | $1,215,018 | -10,954 | -2.3% | $110.92 | 471,085 | 11 Feb 2026 | Direct | F4 |
| transaction | EHC | Encompass Health Common Stock | Sale | $677,718 | -6,057 | -1.3% | $111.89 | 465,028 | 11 Feb 2026 | Direct | F5 |
| transaction | EHC | Encompass Health Common Stock | Sale | $9,923,082 | -87,745 | -19% | $113.09 | 377,283 | 11 Feb 2026 | Direct | F6 |
| transaction | EHC | Encompass Health Common Stock | Sale | $24,193 | -213 | -0.06% | $113.58 | 377,070 | 11 Feb 2026 | Direct |
| Id | Content |
|---|---|
| F1 | This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.47 to $108.45, inclusive. The reporting pers on undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. |
| F2 | This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.47 to $109.17, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. |
| F3 | This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.52 to $110.51, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. |
| F4 | This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.52 to $111.51, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. |
| F5 | This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.55 to $112.53, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. |
| F6 | This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.58 to $113.52, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. |